// App-Quantinova.ai

FRI-499 : MiR-142-3p Regulates Both the Growth Hormone Receptor and the Prolactin Receptor in Breast Cancer Cell Lines

Researchers

Presenter

  • Cynthia Gates Goodyer

Principal Investigators

  • N/A

Medical Centers

  • Research Institute McGill University Health Center, Montreal, Quebec, Canada

  • Montreal University, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Prolactin

  • Growth Hormone 1

Drug/Treatment

  • hGH

  • miR-16

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved